ID
36094
Descripción
Study ID: 101468/198 Clinical Study ID: 101468/198 Study Title:An open, randomised, crossover, healthy volunteer study to compare the PK and tolerability of ropinirole as 3 different new formulations with the standard marketed formulation and to study the effects of a high fat meal on a new formulation Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 1 Study Recruitment Status: Completed Generic Name: ropinirole Trade Name: Modutab,ZIPEREVE,ZEPREVE,REPREVE,ADARTREL,REQUIP,Zygara; Zygara,ZIPEREVE,ZEPREVE,Requip Depot,REQUIP,REPREVE,Modutab,ADARTREL Study Indication : Restless Legs Syndrome The Study consists of a Screening, 5 Sessions each with 2 days and a Follow-up. This document contains the Dosing Details form. It has to be filled in for all sessions each for day 1.
Palabras clave
Versiones (1)
- 15/4/19 15/4/19 -
Titular de derechos de autor
GlaxoSmithKline
Subido en
15 de abril de 2019
DOI
Para solicitar uno, por favor iniciar sesión.
Licencia
Creative Commons BY-NC 3.0
Comentarios del modelo :
Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.
Comentarios de grupo de elementos para :
Comentarios del elemento para :
Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.
Comparison of pharmacokinetic and tolerability of ropinirole in healthy adults, 101468/198
Similar models
Dosing Details
- StudyEvent: ODM
C0040223 (UMLS CUI [1,2])
C0178602 (UMLS CUI [1,2])
C2826892 (UMLS CUI [1,3])
C0806914 (UMLS CUI [2,1])
C2826892 (UMLS CUI [2,2])
C1283174 (UMLS CUI [1,2])
C0178602 (UMLS CUI [1,3])